LWM
TRIB

LBA Wealth Management’s Trinity Biotech TRIB Stock Holding History

LBA Wealth Management’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-55
Closed -$5K – 385
2014
Q3 		$5K Buy
+55
New +$5.96K ﹤0.01% 342

Other funds holding TRIB

HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
CCMLC
Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return
LSC
Lyon Street Capital Sausalito, California $67M AUM
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return
AAM
ACK Asset Management Greenwich, Connecticut $801M AUM 60.42% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return

LBA Wealth Management's TRIB Position: Q4 2014 in Review

LBA Wealth Management sold out of Trinity Biotech (TRIB) in Q4 2014, closing a stake of 55 shares — an estimated $5K sold.

LBA Wealth Management first reported a position in TRIB in Q3 2014 and held it in 1 quarter. The position peaked at $5K in Q3 2014. 92 funds tracked by Wall St. Rank hold TRIB as of Q4 2014.

  • LBA Wealth Management reported no remaining Trinity Biotech position as of Q4 2014 after selling out during the quarter.
  • LBA Wealth Management sold 55 Trinity Biotech shares in Q4 2014, an estimated $5K.
  • LBA Wealth Management first reported a position in Trinity Biotech in Q3 2014 and held it in 1 quarter.
  • LBA Wealth Management's Trinity Biotech position peaked at $5K in Q3 2014.
  • 92 funds tracked by Wall St. Rank held Trinity Biotech as of Q4 2014.

Based on LBA Wealth Management's 13F filing for Q4 2014, filed 4 Feb 2015.